Vijaya Diagnostic Centre Ltd

Q4 FY26Healthcare Services

Vijaya Diagnostic Centre Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,504

Market cap₹14.3K Cr

P/E82.7

Updated23 Aug 2026

Read4 min read

The short version

Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.). Vijaya Diagnostic Centre expects continued double-digit revenue growth, particularly driven by network expansion in Pune, West Bengal, and new hubs in Bangalore.

From Vijaya Diagnostic Centre Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.).
Hyderabad to sustain double-digit growth (~20%) in near term, with additional spokes opening and market share gains.
Pune expected to double revenue in next 3-5 years, with newer hubs targeting INR 12-15 crores revenue per center.
Bangalore hubs showing promising traction with centers nearing break-even; more hubs planned.
Continued double-digit growth in Peripheral Healthcare (PH) and wellness segments.
Focus on volume-driven growth rather than premiumization, with ~1-1.5% realization price hikes.
Genomics is a long-term growth area, with gradual build-up expected but no significant near-term revenue impact.

2 more points management made on revenue & sales performance

Profitability & Margins

Vijaya Diagnostic Centre expects continued double-digit revenue growth, particularly driven by network expansion in Pune, West Bengal, and new hubs in Bangalore.
For FY'27, capex of INR 140-150 crores is planned, focusing on 4-5 new hubs, 10-12 spokes, and a state-of-the-art automated lab to enhance operational efficiency.
EBITDA margins are expected to remain robust above 40%, with potential margin accretion due to the addition of more spokes compared to hubs.
Management is confident of sustaining and potentially exceeding the current EBITDA margin of ~41.5% for the full year despite incremental investments in technology and talent.
Operating leverage benefits and faster breakeven of new centers contribute to profitability growth.

2 more points management made on profitability & margins

See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

FY'26 capex outlay was INR 169 crores, including replacement capex.
FY'27 planned capex for new centers and an automated lab estimated at INR 140-150 crores (Page 5, 12, 17).
Capex includes 4-5 hubs, 10-12 spokes, with leases executed currently; further capex guidance to be revised quarterly as new opportunities arise (Page 7, 9, 17).
Additional INR 10-15 crores allocated for maintenance capex yearly (Page 18).
Expansion focus is organic growth; no immediate inorganic acquisitions, though management remains open if valuation and value-add are right (Page 9).
Flagship hub in Bannerghatta, Bangalore with advanced equipment (PET CT, wide bore MRI) planned to be operational in next few months (Page 9).

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

No specific mention of any current or planned fundraising through debt or equity in the provided transcript.
The company has a strong cash balance of around INR 280-300 crores and plans to use this cash primarily for organic growth and potential inorganic acquisitions if suitable opportunities arise.
Capex for FY27 is estimated between INR 140-150 crores, funded through existing cash and internal accruals.

2 more points management made on fundraising & capital structure

See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Vijaya Diagnostic Centre has been catering to a few large corporates for the last couple of years.
Despite the presence of many aggregators and price-sensitive corporates causing some churn, the company has continuously received orders from large corporates over the past 2-3 years.
No specific quantitative details on the order book or pipeline were shared.
The company sees ongoing continuous orders and repeat business from large corporates.

2 more points management made on order book & pipeline

Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹219 Cr, net profit ₹48 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Vijaya Diagnost.'s management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Vijaya Diagnostic Centre Ltd Q4 FY26 results?

What is Vijaya Diagnostic Centre Ltd share price analysis?

Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 82.7 with a market cap of ₹14,313 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vijaya Diagnostic Centre Ltd planning capital expenditure?

FY'26 capex outlay was INR 169 crores, including replacement capex.

Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.